Om

Optimi Health Corp. is a Canadian pharmaceutical and nutraceutical manufacturer focused on controlled psychedelic drug products and functional mushrooms. The company produces finished-dose MDMA and psilocybin products, along with related ingredients and formulations used in regulated clinical and therapeutic programs. Its current business includes farming, processing, extraction, manufacturing, testing, and distribution of mushroom biomass, mushroom extracts, and supplements, serving authorized clinics, pharmacies, clinical trials, and health and wellness partners. Optimi Health Corp. also supplies botanical and pharmaceutical-grade psychedelic compounds for markets that require compliant, standardized production and traceability. Headquartered in Princeton, British Columbia, and incorporated in 2020, the company plays a specialized role in the emerging regulated market for psychedelic medicines and mushroom-based wellness products.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I OPTIMI HEALTH MED ENDAVU: Køb Optimi Health ($OPTI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Optimi Health, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.